Vaccines Boost Priority Profile Of US FDA’s Biologic Center 2019 Approvals
Executive Summary
Tropical diseases were not neglected by the Center for Biologics Evaluation and Research in 2019, producing three novel vaccines (which earned three priority review vouchers) and tilting the approval class toward expedited review programs.